Table 2.

Pulmonary function, SUVmax and TLuG at baseline and after 26 weeks infliximab treatment, n = 27; mean ± SD

	Baseline	After 26 weeks infliximab	Change	p value
FVC (% predicted)	75.1 ± 18.4	79.7 ± 19.9	+ 4.6 ± 8.4	0.009
FEV1 (% predicted)	58.6 ± 17.9	63.6 ± 20.5	+ 5.1 ± 6.8	0.001
DLCOc (% predicted)a	55.5 ± 17.9	57.9 ± 16.9	+ 2.4 ± 6.8	0.100
SUVmax	8.2 ± 4.7	3.1 ± 2.9	− 5.1 ± 5.1	< 0.001
TLuG	5395 ± 3216	2641 ± 952	− 2755 ± 3064	< 0.001

FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, DLCOc diffusing capacity of the lung for carbon monoxide corrected for haemoglobin, SUVmax maximum standardized uptake value, TLuG total lung glycolysis

^aThree missing values